This notice is to make the general public aware that Kalliste Biotech Fund IC SICAV
plc (“the Scheme”) requested the Malta Financial Services Authority (“MFSA”) to
accept the surrender of the collective investment scheme licence granted in relation to
the Scheme. This surrender is entirely voluntary and does not arise as a result of any
regulatory action taken by the MFSA. Accordingly, with effect from 26 September
2018, the Scheme ceased to be licensed by the MFSA.

MFSA Ref: 79-2018